Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2016 - 2025)

Prestige Consumer Healthcare has reported Other Non-Current Assets over the past 15 years, most recently at $3.8 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $3.8 million for Q4 2025, down 40.16% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 40.16% YoY), and the annual figure for FY2025 was $3.3 million, down 42.83%.
  • Other Non-Current Assets for Q4 2025 was $3.8 million at Prestige Consumer Healthcare, up from $3.4 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for PBH hit a ceiling of $6.7 million in Q3 2024 and a floor of $2.5 million in Q2 2021.
  • Median Other Non-Current Assets over the past 5 years was $3.3 million (2022), compared with a mean of $3.9 million.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 99.84% in 2023 and later plummeted 51.48% in 2025.
  • Prestige Consumer Healthcare's Other Non-Current Assets stood at $2.9 million in 2021, then rose by 9.13% to $3.2 million in 2022, then skyrocketed by 99.84% to $6.3 million in 2023, then increased by 0.57% to $6.3 million in 2024, then tumbled by 40.16% to $3.8 million in 2025.
  • The last three reported values for Other Non-Current Assets were $3.8 million (Q4 2025), $3.4 million (Q3 2025), and $3.0 million (Q2 2025) per Business Quant data.